Contributor Disclosures for Pityriasis Rubra Pilaris

Role Name Disclosure Details Author  Margaret H Rinker, MD, Staff Physician, Clinical Assistant Professor, Department of Dermatology and Cutaneous Surgery, University of South Florida Nothing to disclose Details Coauthor  Philip D Shenefelt, MD, MS, Associate Professor, Department of Dermatology, Division of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine; Chief, Section of Dermatology, James A Haley Veterans Hospital Nothing to disclose Details Medical Editor  Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine Abbott Laboratories Actelion Amgen Astellas Basilea Boehringer-Ingelheim Briston-Myers Squibb Celtic Pharma Centocor Cephalon Chattem DermiPsor Doak DOV Forward Galderma Genentech Genzyme GlaxoSmithKline Graceway Helix BioMedix Isotechnika Ligand Medicis Neosil Novartis OMP Pepgen Pfizer PharmaDerm Roche Stiefel Teva UCB Warner Chilcott Details Pharmacy Editor  Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center Nothing to disclose Details Managing Editor  Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine Amgen Abbott Electrical Optical Sciences Centocor Details CME Editor  Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania AMGEN AMGEN Genentech Centocor Centocor Covance Shire Details Chief Editor  Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Margaret H Rinker, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Philip D Shenefelt, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mark G Lebwohl  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Abbott Laboratories Honoraria Consulting   Actelion Honoraria Consulting   Amgen Honoraria Consulting   Astellas Honoraria Consulting   Basilea Honoraria Consulting   Boehringer-Ingelheim Honoraria Consulting   Briston-Myers Squibb Honoraria Consulting   Celtic Pharma Honoraria Other   Centocor Honoraria Consulting   Cephalon Honoraria Consulting   Chattem Honoraria Other   DermiPsor Honoraria Consulting   Doak Honoraria Other   DOV Honoraria Consulting   Forward Honoraria Consulting   Galderma Honoraria Consulting   Genentech Honoraria Consulting   Genzyme Honoraria Consulting   GlaxoSmithKline Honoraria Consulting   Graceway Honoraria Consulting   Helix BioMedix Honoraria Consulting   Isotechnika Honoraria Consulting   Ligand Honoraria Other   Medicis Honoraria Investigator   Neosil Honoraria Consulting   Novartis Honoraria Consulting   OMP Honoraria Other   Pepgen Honoraria Consulting   Pfizer Honoraria Consulting   PharmaDerm Honoraria Other   Roche Honoraria Consulting   Stiefel Honoraria Consulting   Teva Honoraria Consulting   UCB Honoraria Consulting   Warner Chilcott Honoraria Review panel membership   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Michael J Wells  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Jeffrey P Callen  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Amgen Honoraria Consulting   Abbott Honoraria Consulting   Electrical Optical Sciences Honoraria Consulting   Centocor Honoraria Consulting   Off label or investigational use of medication Each chapter has medications that are "off label" in each instance I have indicated the level of evidence that exists. CONTRIBUTOR DISCLOSURE FORM Contributor Name: Joel M Gelfand  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** AMGEN Consulting fee Consulting   AMGEN Grant/research funds None   Genentech Consulting fee Consulting   Centocor Consulting fee Consulting   Centocor Grant/research funds None   Covance Consulting fee Consulting   Shire Consulting fee Consulting   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Dirk M Elston  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication